Yin WD - Search Results

1

Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.

Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP. Wu J, et al. Among authors: yin wd. Clin Infect Dis. 2009 Apr 15;48(8):1087-95. doi: 10.1086/597401. Clin Infect Dis. 2009. PMID: 19281330 Clinical Trial.

2

[Serological investigation on close contacts to patients with severe acute respiratory syndrome in an SARS outbreak].

Xie SY, Zeng G, Chen JT, Liu YX, Li SF, Yin WD. Xie SY, et al. Among authors: yin wd. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Oct;25(10):867-9. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15631743 Chinese.

3

A serological survey on neutralizing antibody titer of SARS convalescent sera.

Zhang JS, Chen JT, Liu YX, Zhang ZS, Gao H, Liu Y, Wang X, Ning Y, Liu YF, Gao Q, Xu JG, Qin C, Dong XP, Yin WD. Zhang JS, et al. Among authors: yin wd. J Med Virol. 2005 Oct;77(2):147-50. doi: 10.1002/jmv.20431. J Med Virol. 2005. PMID: 16121363 Free PMC article.

4

Preparation and characterization of SARS in-house reference antiserum.

Zhang J, Liu Y, Hu L, Gao Q, Zhang Z, Zhang X, Chen J, Gong X, Song L, Liu Y, Li J, Li S, Huang J, Ning Y, Gao H, Qin C, Dong X, Wei J, Dong G, Yin W. Zhang J, et al. Vaccine. 2005 Dec 1;23(48-49):5666-9. doi: 10.1016/j.vaccine.2004.12.032. Epub 2005 Mar 16. Vaccine. 2005. PMID: 16269206 Free PMC article.

5

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

Lin J, Zhang J, Dong X, Fang H, Chen J, Su N, Gao Q, Zhang Z, Liu Y, Wang Z, Yang M, Sun R, Li C, Lin S, Ji M, Liu Y, Wang X, Wood J, Feng Z, Wang Y, Yin W. Lin J, et al. Lancet. 2006 Sep 16;368(9540):991-7. doi: 10.1016/S0140-6736(06)69294-5. Lancet. 2006. PMID: 16980114 Clinical Trial.

6

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.

Lin JT, Zhang JS, Su N, Xu JG, Wang N, Chen JT, Chen X, Liu YX, Gao H, Jia YP, Liu Y, Sun RH, Wang X, Yu DZ, Hai R, Gao Q, Ning Y, Wang HX, Li MC, Kan B, Dong GM, An Q, Wang YQ, Han J, Qin C, Yin WD, Dongs XP. Lin JT, et al. Among authors: yin wd. Antivir Ther. 2007;12(7):1107-13. Antivir Ther. 2007. PMID: 18018769 Clinical Trial.

7

Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.

Jiang WP, Chen JT, Wang X, Wang YL, Liu Y, Chen WY, Xu WG, Qiu YZ, Yin WD. Jiang WP, et al. Among authors: yin wd. Vaccine. 2008 Apr 24;26(18):2297-301. doi: 10.1016/j.vaccine.2007.11.008. Epub 2007 Nov 26. Vaccine. 2008. PMID: 18395305 Clinical Trial.

8

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China.

Wang H, Feng Z, Shu Y, Yu H, Zhou L, Zu R, Huai Y, Dong J, Bao C, Wen L, Wang H, Yang P, Zhao W, Dong L, Zhou M, Liao Q, Yang H, Wang M, Lu X, Shi Z, Wang W, Gu L, Zhu F, Li Q, Yin W, Yang W, Li D, Uyeki TM, Wang Y. Wang H, et al. Lancet. 2008 Apr 26;371(9622):1427-34. doi: 10.1016/S0140-6736(08)60493-6. Epub 2008 Apr 8. Lancet. 2008. PMID: 18400288

9

[Immunogenicity and safety of three consecutive lots on an inactivated hepatitis A vaccine: a double-blind, immunogenicity and safety of three consecutive lots on a inactivated hepatitis A vaccine:a double-blind, randomized and controlled trial in children].

Jiang WP, Wang YL, Chen WY, Xu WG, Chen JT, Wang X, Liu Y, Yin WD. Jiang WP, et al. Among authors: yin wd. Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jun;29(6):556-9. Zhonghua Liu Xing Bing Xue Za Zhi. 2008. PMID: 19040036 Clinical Trial. Chinese.

10

Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine.

Lin JT, Li CG, Wang X, Su N, Liu Y, Qiu YZ, Yang M, Chen JT, Fang HH, Dong XP, Yin WD, Feng ZJ. Lin JT, et al. Among authors: yin wd. J Infect Dis. 2009 Jan 15;199(2):184-7. doi: 10.1086/595832. J Infect Dis. 2009. PMID: 19067606 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters